Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Healthtrust
Cerilliant
Chubb
Argus Health
AstraZeneca
Covington
Citi
Farmers Insurance
Fuji

Generated: October 21, 2017

DrugPatentWatch Database Preview

Patents Expiring in January 2020

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Amarin Pharms
VASCEPA
icosapent ethyl
CAPSULE;ORAL202057-002Feb 16, 2017RXYesNo► Subscribe► SubscribeYY
Astrazeneca Pharms
DALIRESP
roflumilast
TABLET;ORAL022522-001Feb 28, 2011RXYesYes► Subscribe► SubscribeYY TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS
Leo Pharma As
ENSTILAR
betamethasone dipropionate; calcipotriene
AEROSOL, FOAM;TOPICAL207589-001Oct 16, 2015RXYesYes► Subscribe► SubscribeY PLAQUE PSORIASIS
Amarin Pharms
VASCEPA
icosapent ethyl
CAPSULE;ORAL202057-001Jul 26, 2012RXYesYes► Subscribe► SubscribeYY
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY TREATMENT OF MODERATE PLAQUE PSORIASIS
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY PLAQUE PSORIASIS
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL021852-001Jan 9, 2006ABRXYesYes► Subscribe► SubscribeY PSORIASIS
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY PSORIASIS
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL021852-001Jan 9, 2006ABRXYesYes► Subscribe► SubscribeY TREATMENT OF MODERATE PLAQUE PSORIASIS
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY TREATMENT OF MODERATE PLAQUE PSORIASIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Julphar
Cerilliant
Accenture
Chubb
Farmers Insurance
Cantor Fitzgerald
Queensland Health
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot